BDBM645531 4-{[6-(5-chloro-2-fluorophen- yl)pyridazin-4-yl]amino}- quinolin-7-yl 4-[2-(1-methyl- piperidin-4-yl)ethyl]piper- azine-1-carboxylate::US20240018122, Example 64

SMILES CN1CCC(CCN2CCN(CC2)C(=O)Oc2ccc3c(Nc4cnnc(c4)-c4cc(Cl)ccc4F)ccnc3c2)CC1

InChI Key InChIKey=VRJHICQKQLIMLE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 645531   

TargetTGF-beta receptor type-1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM645531(US20240018122, Example 64 | 4-{[6-(5-chloro-2-fluo...)
Affinity DataIC50: 1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/13/2024
Entry Details
US Patent